title: Effect of Liraglutide on Corneal Kindling Epilepsy Induced Depression and Cognitive Impairment in Mice.
abstract: GLP-1 play important role in neuroprotection and GLP-1 receptor deficit mice showed decreased seizure threshold and increased cognitive impairment. Therefore, study was premeditated to investigate the effect of liraglutide (GLP-1 analogue) on cornel kindling epilepsy induced co-morbidities in mice. Corneal kindling was induced by electrical stimulation (6 mA, 50 Hz, 3 s); twice daily for 13 days. Liraglutide (75 and 150 µg/kg) and phenytoin (20 mg/kg) were administered in corneal kindled groups. On day 14, elevated plus maze, passive shock avoidance paradigms were performed, and on day 15, retention was taken. On day 16 tail suspension test were performed. On 20th day challenge test was performed with same electrical stimulation and retention was observed on elevated plus maze and passive avoidance paradigm. Animal were sacrificed on 21st day for biochemical (LPO, GSH, and nitrite) and neurochemical (GABA, glutamate, DA, NE, 5-HT and their metabolites) estimation. Electrical stimulation by corneal electrode for 13 days developed generalized clonic seizures, increased cognitive impairment, oxidative stress and neurochemical alteration in mice brain. Co-treatment with liraglutide (75 and 150 μg/kg) significantly prevented the seizure severity, restored behavioural activity, oxidative stress and restored the altered level of neurotransmitters observed in corneal kindled mouse.
authors.affiliation: Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Ferozepur Road, Ghal Kalan, Moga, Punjab, 142001, India.
authors.forename: Prashant
authors.initials: P
authors.lastname: Koshal
authors.affiliation: Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Ferozepur Road, Ghal Kalan, Moga, Punjab, 142001, India. punnubansal79@gmail.com.
authors.forename: Puneet
authors.initials: P
authors.lastname: Kumar
mesh_terms: D000818:Animals; D060825:Cognitive Dysfunction / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D003315:Cornea / Q000502:physiology; D003863:Depression / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D004827:Epilepsy / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D007696:Kindling, Neurologic / Q000187:drug effects* / Q000502:physiology; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D000069450:Liraglutide / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D016896:Treatment Outcome
chemical_list: D000069450:Liraglutide
keywords: Cognitive impairment; Depression; Epilepsy; GLP-1; Liraglutide; Neurotransmitters; Oxidative stress